Abstract:Mutations in (cid:98) or (cid:103) subunit of the epithelial sodium channel (ENaC) have been found to cause a hereditary form of human hypertension, Liddle syndrome. Most of the mutations reported are either nonsense mutations or frame shift mutations which would truncate the cytoplasmic carboxyl terminus of the (cid:98) or (cid:103) subunits of the channel, suggesting that these domains are important for the normal regulation of this channel. We sequenced ENaC in a family with Liddle syndrome and found a missense mutation in (cid:98) subunit which predicts substitution of Tyr by His at codon 618, 2 bp downstream from a missense mutation (P616L) that has been reported recently. Presence of this mutation correlates with the clinical manifestations (hypertension, hypokalemia, suppressed aldosterone secretion) in this kindred. Functional expression studies in the Xenopus oocytes revealed constitutive activation of the Y618H mutant indis-tinguishable from that observed for the deletion mutant (R564stop) identified in the original pedigree of Liddle. Our data suggest that the region between Pro616 and Tyr618 is critically important for regulation of ENaC activity. ( J. Clin. Invest. 1996. 97:1780–1784.) product was elongated. The third step amplified the mutated cDNA using a 3 (cid:57) primer which primes the synthesis of DNA containing the unrelated sequence. The final PCR product carrying the desired mutation was digested and ligated into the (cid:98) rENaC cDNA wild-type at the Sac1 and Spe1 cleavage sites. The mutation was verified by sequencing. cRNA of (cid:97) , (cid:98) , and (cid:103) subunits was synthesized in vitro, and 5–8 ng cRNA encoding the three (cid:97) , (cid:98) , (cid:103) subunits was injected into stage V and VI oocytes. 20–24 h after injection, amiloride-sensitive Na (cid:49) current expressed by the injected oocytes was measured using the two electrode voltage-clamp technique. The amiloride-sensitive current was measured at a membrane potential of (cid:50) 100 mV in the presence or absence of 5 (cid:109) M amiloride in the bathing medium. The bathing medium contained (mM): NaCl 115, KCl 5, CaCl 2 1.8, Hepes-NaOH 10 (pH 7.2). A mean amiloride-sensitive current was determined in five to eight oocytes originating from the same animal, and injected either with the (cid:98) rENaC wild-type, the (cid:98) subunit deletion mutant at position R564 ( (cid:98) R564stop), or the (cid:98) Y618H mutant, together with (cid:97) rENaC and (cid:103) rENaC. The experiment was repeated eight times with oocytes from different animals. Statistical significance of the results was found using Student’s t test.

Rapid Liddle Disease Caused by a Missense Mutation of (cid:98) Subunit of the Epithelial Sodium Channel Gene

Case Report: A New Peroxisome Proliferator-Activated Receptor Gamma Mutation Causes Familial Partial Lipodystrophy Type 3 in a Chinese Patient

A cohort analysis of familial partial lipodystrophy from two Mediterranean countries

Genomic and Bioinformatics Analysis of Familial Partial Lipodystrophy Type 3 Identified in a Patient with Novel PPARγ Mutation and Robust Response to Pioglitazone

Familial partial lipodystrophy syndromes

Comprehensive analysis of morbidity and mortality patterns in familial partial lipodystrophy patients: insights from a population study

Thermodynamics of micelle formation of the counterion coupled gemini surfactant Bis(4-(2-dodecyl)benzenesulfonate)-Jeffamine salt and its dynamic adsorption on sandstone.

Familial partial lipodystrophy type 3 complicated with recurrent pancreatitis: clinical analysis and literature review

Bacteriological Profile of Bile in Patients Undergoing Cholecystectomy

[The functions of arginase, urease and ornithine-transcarbamylase of the rumen. II. Ornithine-transcarbamylase (Ot-ase) function)].

Circulating exosomal circRNA-miRNA-mRNA network in a familial partial lipodystrophy type 3 family with a novel PPARG frameshift mutation c.418dup

Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance

Whole-exome Sequencing Identifies ADRA2A Mutation in Atypical Familial Partial Lipodystrophy

Case report: First Chinese patient with family partial lipodystrophy type 6 due to novel compound heterozygous mutations in the LIPE gene

Case Report: Concurrent de novo pathogenic variants in the LMNA gene as a cause of sporadic partial lipodystrophy

Lipodystrophy Prevalence, "Lipodystrophy-Like Phenotypes," and Diagnostic Challenges

Genotype - phenotype correlation in an adolescent girl with pathogenic PPARy genetic variation that caused severe hypertriglyceridemia and early onset type 2 diabetes

Clinical and imaging features of women with polygenic partial lipodystrophy: a case series

Precision medicine: toward restoring fat with gene therapy in inherited lipodystrophy

Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction

Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in PLIN1-Related Lipodystrophy